🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Beijing Tsinghua Chang Gung Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Beijing Tsinghua Chang Gung Hospital as lead sponsor. Synced 27 Sep 2026
29Current trials
16Recruiting now
5Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Beijing Tsinghua Chang Gung Hospital is the lead sponsor of 29 current clinical trials in our China register. 16 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Propofol, Remimazolam and Atorvastatin. The most-studied condition is Choledochal Cyst.

ClinicalTrials.gov trials by status

  • Recruiting1655%
  • Not yet open1034%
  • Active, closed13%
  • By invitation27%

Trials by phase

  • Observational1448%
  • Not applicable1034%
  • Phase 4414%
  • Phase 213%
01

Clinical trials sponsored by Beijing Tsinghua Chang Gung Hospital

29 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Efficacy and Safety of Surgical Treatment for Type IVa CBD
NCT07036848 · Choledochal Cyst
Observational Recruiting 2025-07 China
PTC-Guided Therapy for Peritoneal Mesothelioma
NCT07330271 · ClinicalTrials.gov ↗ · Peritoneal Mesothelioma
Not applicable Recruiting 2025-12 China
Prediction Model for MINS After Major Hepatobiliary Surgery
NCT07335042 · ClinicalTrials.gov ↗ · Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm
Observational Recruiting 2026-01 China
Assessing the Efficacy of a Preoperative Navigation System in Anterior Cruciate Ligament Reconstruction
NCT06858930 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament Rupture
Not applicable Recruiting 2025-01 China
The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes
NCT06750783 · ClinicalTrials.gov ↗ · Prediabetic State (IGT)
Phase 4 Recruiting 2024-12 China
SCS Therapy for Patients With Bladder and Bowel Dysfunction After SCI
NCT07511244 · ClinicalTrials.gov ↗ · Bladder and Bowel Dysfunction, SCI - Spinal Cord Injury
Not applicable Recruiting 2024-12 China
Unveiling the Neural Mechanisms of 5-HT7 in Sleep Apnea Induced by Arousal Dysregulation
NCT06608888 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea
Observational Recruiting 2024-08 China
Digital Early Warning System for Acute Lung Injury in Liver Surgery
NCT07070362 · ClinicalTrials.gov ↗ · Acute Lung Injury(ALI), Liver Cirrhosis, ARDS, Human
Observational Recruiting 2024-11 China
AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma
NCT07538882 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma (HCC)
Observational Recruiting 2026-04 China
The Effect of PAP on ISSHL Comorbided With OSA
NCT04192656 · ClinicalTrials.gov ↗ · Sudden Hearing Loss, Obstructive Sleep Apnea
Phase 4 Recruiting 2019-11 China
Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism
NCT07724197 · ClinicalTrials.gov ↗ · Pulmonary Embolism Acute
Observational Recruiting 2026-01 China
Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)
NCT04567121 · ClinicalTrials.gov ↗ · Lifestyle Intervention, Non Communicable Diseases
Not applicable Recruiting 2018-01 China
Expression of Target in Endometriotic Lesions
NCT07693283 · ClinicalTrials.gov ↗ · Endometriosis
Observational Recruiting 2026-04 China
Biliary Dilatation National Special Disease Cohort in China
NCT06881004 · ClinicalTrials.gov ↗ · Choledochal Cyst
Observational Recruiting 2025-03 China
One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei
NCT07328737 · ClinicalTrials.gov ↗ · Pseudomyxoma Peritonei
Not applicable Recruiting 2025-11 China
APP-based Precise Management System of Chronic Intractable Pain
NCT05761392 · ClinicalTrials.gov ↗ · Pain, Chronic, Pain, Intractable
Not applicable Recruiting 2022-09 China
A Population-based Cohort of Osteoarthritis: the Tsinghua University Tiantongyuan Community Osteoarthritis Study
NCT07006701 · ClinicalTrials.gov ↗ · Osteoarthritis
Observational Not yet open 2025-06 China
AI-Assisted Blood Pressure Control During Anesthesia
NCT07123675 · ClinicalTrials.gov ↗ · Intraoperative Hypotension, Hemodynamic Instability
Not applicable Not yet open 2026-06 China
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures
NCT07575256 · ClinicalTrials.gov ↗ · PCL - Posterior Cruciate Ligament Deficiency, Posterior Cruciate Ligament Tear, PCL - Posterior Cruciate Ligament Rupture
Not applicable Not yet open 2026-05 China
Remimazolam Versus Propofol for Maintenance of Anaesthesia During Major Hepatectomy Under Low Central Venous Pressure
NCT07789275 · ClinicalTrials.gov ↗ · Intraoperative Hypotension, Hepatectomy
Phase 4 Not yet open 2026-08 China
Wearable ECG for AF Screening and Stroke Risk Assessment
NCT06907264 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Stroke
Observational Not yet open 2025-04 China
Relationship Between FGF19 Overexpression and Disease Prognosis
NCT06938451 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma (HCC)
Observational Not yet open 2025-05 China
A Multi-Center Bidirectional Cohort Study on Total Knee Arthroplasty for the Treatment of Knee Osteoarthritis
NCT06990594 · ClinicalTrials.gov ↗ · Osteoarthritis
Observational Not yet open 2025-06 China
Host-Microbe Interactions in Biliary Dilatation
NCT07152496 · ClinicalTrials.gov ↗ · Choledochal Cyst
Observational Not yet open 2025-12 China
Remimazolam Versus Propofol for Early Recovery After Cytoreductive Surgery
NCT07785557 · ClinicalTrials.gov ↗ · Peritoneal Neoplasms, Postoperative Recovery
Not applicable Not yet open 2026-08 China
Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .
NCT06632522 · ClinicalTrials.gov ↗ · Liver Cancer
Phase 2 Not yet open 2024-10 China
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
NCT06925334 · ClinicalTrials.gov ↗ · Type 2 Diabetic Patients
Phase 4 By invitation 2024-05 China
AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer
NCT07042841 · ClinicalTrials.gov ↗ · Liver Cancer, Adult
Observational By invitation 2015-06 China
ThromBus Aspiration for Acute Mesenteric Artery Occlusion With Emergent Laparoscopic Surgery
NCT07741318 · ClinicalTrials.gov ↗ · Acute Mesenteric Ischemia
Not applicable Active, closed 2026-07 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Beijing Tsinghua Chang Gung Hospital trials

5 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Beijing Tsinghua Chang Gung Hospital trials

39 conditions
Choledochal Cyst3Osteoarthritis2Intraoperative Hypotension2Hepatocellular Carcinoma (HCC)2Obstructive Sleep Apnea2Peritoneal Mesothelioma1Type 2 Diabetic Patients1Hemodynamic Instability1Myocardial Injury After Noncardiac Surgery (MINS)1Postoperative Complications1Liver Neoplasm1Hepatobiliary Diseases1Liver Cancer, Adult1Anterior Cruciate Ligament Rupture1Prediabetic State (IGT)1PCL - Posterior Cruciate Ligament Deficiency1Posterior Cruciate Ligament Tear1PCL - Posterior Cruciate Ligament Rupture1Hepatectomy1Atrial Fibrillation1Stroke1Acute Mesenteric Ischemia1Bladder and Bowel Dysfunction1SCI - Spinal Cord Injury1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China2916

A trial with sites in more than one country appears in each of those registers.

05

Questions about Beijing Tsinghua Chang Gung Hospital trials

How many clinical trials does Beijing Tsinghua Chang Gung Hospital sponsor?

Beijing Tsinghua Chang Gung Hospital is the lead sponsor of 29 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Beijing Tsinghua Chang Gung Hospital trials recruiting?

Yes. 16 of its 29 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Beijing Tsinghua Chang Gung Hospital testing?

Its current trials name 5 drugs and biologicals as interventions. The most frequent are Propofol (2), Remimazolam (2), Atorvastatin (1), Degludec insulin (1) and Methylprednisolone (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.